Acura Pharmaceuticals (OTC: ACUR)
Acura Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Acura Pharmaceuticals Company Info
Acura Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. Its technology platforms include AVERSION, IMPEDE, and LIMITX. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.
News & Analysis
3 Companies That Put the "Tech" in "Biotech"
From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."
Whoa! What Just Happened to My Stock?
These stocks bounced higher yesterday, but are they about to make a return trip to Earth?
CAPScall of the Week: Acura Pharmaceuticals
A weekly adventure in giving unknown companies some attention.
3 Stocks to Get on Your Watchlist
Are these three stocks about to make a large move?
This Week in Biotech
A look at the biggest stories this week in biotech and what they mean for investors.
Why Acura Is Poised to Pull Back
Market-lagging returns could be written in this 1-Star.
Acura Investors: Why Shares Popped 70%
Another abuse-resistant drug for Acura sees a huge jump in share price.
The Dow Catches Its Breath
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.